These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38296804)

  • 1. Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease.
    Bausson J; Keller N; Von Hunolstein JJ; Sacrez M; Michel B; Gourieux B; Fourtage M; Felten R
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.
    Pisaniello HL; Fisher MC; Farquhar H; Vargas-Santos AB; Hill CL; Stamp LK; Gaffo AL
    Arthritis Res Ther; 2021 Apr; 23(1):130. PubMed ID: 33910619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
    Pascart T; Lancrenon S; Lanz S; Delva C; Guggenbuhl P; Lambert C; Aubert JP; Saraux A; Ea HK; Lioté F
    Joint Bone Spine; 2016 Dec; 83(6):687-693. PubMed ID: 26919801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
    Whelan MG; Hayashi K; Altwies H; Tedeschi SK
    J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial.
    Pascart T; Robinet P; Ottaviani S; Leroy R; Segaud N; Pacaud A; Grandjean A; Luraschi H; Rabin T; Deplanque X; Maciejasz P; Visade F; Mackowiak A; Baclet N; Maréchaux S; Lefebvre A; Budzik JF; Bardin T; Richette P; Norberciak L; Ducoulombier V; Houvenagel E
    Lancet Rheumatol; 2023 Sep; 5(9):e523-e531. PubMed ID: 38251496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
    Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    Rheumatology (Oxford); 2021 Dec; 61(1):223-229. PubMed ID: 33764413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
    Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of calcium pyrophosphate crystal deposition disease: A systematic review.
    Parperis K; Papachristodoulou E; Kakoullis L; Rosenthal AK
    Semin Arthritis Rheum; 2021 Feb; 51(1):84-94. PubMed ID: 33360232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Patients with Gout and Kidney Disease: A Review of Available Therapies and Common Missteps.
    Kannuthurai V; Gaffo A
    Kidney360; 2023 Sep; 4(9):e1332-e1340. PubMed ID: 37526648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Roth ME; Chinn ME; Dunn SP; Bilchick KC; Mazimba S
    Clin Cardiol; 2022 Jul; 45(7):733-741. PubMed ID: 35481608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial.
    Yang DH; Chen HC; Wei JC
    Eur J Med Res; 2023 Jan; 28(1):10. PubMed ID: 36609359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.
    Loustau C; Rosine N; Forien M; Ottaviani S; Juge PA; Lioté F; Bardin T; Richette P; Dieudé P; Richez C; Bannwarth B; Schaeverbeke T; Ea HK; Truchetet ME
    Joint Bone Spine; 2018 Dec; 85(6):755-760. PubMed ID: 29654950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine use and the risk of CKD progression: a multicentre nested case-control study.
    Kim HW; Joo YS; Yun HR; Kim JY; Jhee JH; Roh YH; Park JT; Chang TI; Yoo TH; Kang SW; Han SH
    Rheumatology (Oxford); 2022 Nov; 61(11):4314-4323. PubMed ID: 35139160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial.
    Stamp L; Horne A; Mihov B; Drake J; Haslett J; Chapman PT; Frampton C; Dalbeth N
    Ann Rheum Dis; 2023 Dec; 82(12):1626-1634. PubMed ID: 37652661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium pyrophosphate deposition (CPPD) disease - Treatment options.
    Stack J; McCarthy G
    Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101720. PubMed ID: 34756508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of colchicine-induced myopathy in a patient with chronic kidney disease].
    DU YJ; Liu WC; Chen X; Cheng YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1188-1190. PubMed ID: 34916703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine gastrotoxicity in a patient with chronic kidney disease.
    Ho GCH; Lau WH; Leung MH
    Rheumatology (Oxford); 2019 Dec; 58(12):2229. PubMed ID: 31056709
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares.
    Latourte A; Pascart T; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):387-393. PubMed ID: 32422339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adsorption in refractory chronic gouty arthritis flare: A case report.
    Lei Y; Cui TJ; Wang XH; Zhang XM; Tang C; Zheng ZH
    Front Immunol; 2022; 13():1045982. PubMed ID: 36505444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.